Literature DB >> 10048963

A study of adult T-cell leukemia/lymphoma incidence in central Brooklyn.

P H Levine1, H Dosik, E M Joseph, S Felton, M A Bertoni, J Cervantes, V Moulana, A B Miotti, L J Goberdhan, S L Lee, A Daouad, M DaCosta, E S Jaffe, C A Axiotis, F R Cleghorn, A Kahn, S L Welles.   

Abstract

Adult T-cell leukemia/lymphoma (ATL), a rare outcome of infection with human T-lymphotropic virus (HTLV-I), is endemic in central Brooklyn, which has a large Caribbean migrant population. Previous studies have suggested that HTLV-I prevalence in central Brooklyn may be similar to that recorded in the Caribbean islands. We established a pilot 1-year surveillance program to identify cases of ATL in 7 of 10 hospitals serving the residents of 18 zip codes of central Brooklyn with a combined population of 1,184,670. Of the 6,198 in-patient beds in the catchment area, approximately 83% were covered. Twelve incident cases of ATL were ascertained, all among persons of Afro-Caribbean descent, indicating an annual incidence in African-Americans in this community of approximately 3.2/100,000 person-years. Unexplained hypercalcemia was the most useful screening method, identifying 3 of 5 patients not referred for possible ATL by a local hematologist. The female:male ratio was 3:1. The age pattern was different from that reported in the Caribbean Basin and closer to the pattern seen in Japan. Our study supports evidence that HTLV-I infection and ATL are endemic in central Brooklyn and suggests that a more intensive surveillance program for this disease coupled with intervention efforts to reduce HTLV-I transmission are warranted.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048963     DOI: 10.1002/(sici)1097-0215(19990301)80:5<662::aid-ijc5>3.0.co;2-i

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

Review 1.  Incidence of adult T-cell leukemia/lymphoma in nonendemic areas.

Authors:  Noriaki Yoshida; Dai Chihara
Journal:  Curr Treat Options Oncol       Date:  2015-02

2.  Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe?

Authors:  Michael R Marvin; Guy N Brock; Kwadwo Kwarteng; Ravi Nagubandi; Kadiyala V Ravindra; Mary Eng; Joseph F Buell
Journal:  Transplantation       Date:  2009-04-27       Impact factor: 4.939

3.  Adult T-cell leukemia: a review of epidemiological evidence.

Authors:  Masako Iwanaga; Toshiki Watanabe; Kazunari Yamaguchi
Journal:  Front Microbiol       Date:  2012-09-10       Impact factor: 5.640

Review 4.  A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies.

Authors:  Olivier Hermine; Juan Carlos Ramos; Kensei Tobinai
Journal:  Adv Ther       Date:  2018-02-06       Impact factor: 3.845

5.  Clinical Characteristics and Outcomes of Caribbean Patients With Adult T-Cell Lymphoma/Leukemia at Two Affiliated New York City Hospitals.

Authors:  Edwin Chiu; Bachar Samra; Eric Tam; Babak Baseri; Bo Lin; Carol Luhrs; Jason Gonsky; Ahmed Sawas; Evelyn Taiwo; Gurinder Sidhu
Journal:  JCO Glob Oncol       Date:  2020-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.